Cocrystal Pharma sells 5,474,053 shares to OPKO in USD 5 million private placement
COCP•Operational update
OPKO Health increased its stake as Cocrystal targets Phase 1b norovirus topline data in Q4 2026.
Private placement with OPKO Health
Cocrystal Pharma priced a USD 5 million private placement with OPKO Health, selling 5,474,053 common shares at USD 0.91 each.
The deal used the Nasdaq Consolidated Bid Price on the closing day; no warrants or other derivative securities were included.
